Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 334 across all filing types
Latest filing 2021-10-07 Investor Presentation
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Investor Presentation Classification · 90% confidence The document is a press release announcing that NeonMind Biosciences Inc. will present at the KCSA Psychedelics Virtual Investor Conference on October 14th. It includes details about the event, the company's business focus, and contact information. There is no financial data, no report attached or referenced as being published, and no regulatory filing or certification. The content is clearly an announcement of an investor presentation event rather than the presentation itself or a financial report. Therefore, the document best fits the category of Investor Presentation (IP) announcement, but since it is only announcing the presentation and not providing the presentation materials, it is closest to an Investor Presentation (IP) type as it focuses on investor communication and company strategy overview. Given the length and content, it is not a report publication announcement or regulatory filing. Hence, the classification is Investor Presentation (IP) with high confidence.
2021-10-07 English
News release - English.pdf
Regulatory Filings
2021-09-28 English
News release - English.pdf
Regulatory Filings
2021-09-22 English
Material document(s).pdf
Merger & Acquisition Classification · 100% confidence The document is titled 'Asset Purchase Agreement' and dated September 10, 2021. It details the terms and conditions of an asset purchase transaction between two companies, including definitions, purchase price, vendor liabilities, representations and warranties, and covenants. The content is a legal contract related to a merger or acquisition transaction rather than a financial report, regulatory filing, or announcement. It does not contain financial statements, earnings data, or governance information. Therefore, it fits best under the category of Merger & Acquisition (MA), which covers merger, acquisition, and tender-offer filings including agreements related to such transactions.
2021-09-20 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 51-102F3 Material Change Report' and details a specific material change event involving the disposition of assets by NeonMind Biosciences Inc. It includes dates, a summary, and a full description of the material change. This form is a regulatory filing used to disclose material changes to the public and regulators. The document is relatively short (1607 characters) and does not contain financial statements or detailed financial analysis. It is not an annual or interim report, nor an earnings release. It is a specific regulatory disclosure about a material change event, fitting best under Regulatory Filings (RNS).
2021-09-20 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new expert to the company's Specialty Clinic Advisory Board. It focuses on management and advisory board changes, specifically the addition of Dr. Roumen Milev to the board. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no capital changes, and no report publication. The content is about management/board information and expertise addition. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 7420 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data.
2021-09-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.